University of Texas's MD Anderson Cancer: Study Defines Stem Cell Groups That Drive Myelodysplastic Syndromes, Finds Potential Targeted Therapy Option
March 03, 2022
March 03, 2022
HOUSTON, Texas, March 3 (TNSJou) -- The University of Texas's MD Anderson Cancer Center issued the following news release:
* * *
MD Anderson-led study analyzed largest cohort of myelodysplastic syndromes (MDS) samples
* * *
Researchers from The University of Texas MD Anderson Cancer Center discovered that treatment resistance in patients with myelodysplastic syndromes (MDS) is caused by two distinct classes of stem cells and identified pos . . .
* * *
MD Anderson-led study analyzed largest cohort of myelodysplastic syndromes (MDS) samples
* * *
Researchers from The University of Texas MD Anderson Cancer Center discovered that treatment resistance in patients with myelodysplastic syndromes (MDS) is caused by two distinct classes of stem cells and identified pos . . .